INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -12.9% | 2,750 | 0.0% | 0.00% | – |
| Q2 2023 | $1,228 | -45.5% | 2,750 | 0.0% | 0.00% | – |
| Q1 2023 | $2,255 | -47.4% | 2,750 | 0.0% | 0.00% | – |
| Q4 2022 | $4,290 | -14.2% | 2,750 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -28.6% | 2,750 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -30.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -3.8% | 2,750 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +8.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2020 | $32,000 | -56.8% | 2,750 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $74,000 | +270.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | +122.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | -9.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -26.7% | 2,750 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +36.4% | 2,750 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 2,750 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | +18.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -42.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -26.9% | 2,750 | 0.0% | 0.00% | – |
| Q3 2016 | $26,000 | +4.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | +4.2% | 2,750 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | +33.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | +12.5% | 2,750 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | -27.3% | 2,750 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2015 | $22,000 | -12.0% | 2,750 | 0.0% | 0.00% | – |
| Q4 2014 | $25,000 | -7.4% | 2,750 | 0.0% | 0.00% | – |
| Q3 2014 | $27,000 | -10.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | – | 2,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |